Precision Medicine and Personalized Care with George Sledge, MD

In this episode, host Shikha Jain, MD, speaks with George Sledge, MD, about patient feedback benefiting leadership decision-making, the future of precision medicine in oncology and more. •    Welcome to another exciting episode of Oncology Overdrive :58 •    About Sledge 1:03 •    The interview 2:59 •    How did you become an oncologist? 3:24 •    Tell us about your journey into leadership in oncology. 5:27 •    Did you continue to see patients while leading organizations?  7:48 •    Jain and Sledge on learning from conversations and experiences with patients. 10:57 •    How did you end up in your previous position as ASCO president?  12:29 •    Do you feel that ASCO is an organization that is adept at adapting to change? 14:37 •    Tell us about Caris Life Sciences and how you pivoted to your role as executive vice president and CMO there. 18:44 •    Where do you see the future of oncology going? 23:00 •    Jain and Sledge on the concerns surrounding artificial intelligence and technology in cancer care and the doctor patient relationship. 26:31 •    What is something aspirational that you think could change the way we deliver cancer care years from now? 31:11 •    If someone could only listen to the last minute of this episode, what would you want them to take away? 35:21 •    How to contact Sledge 36:37 •    Thanks for listening 37:10 George Sledge, MD, serves as executive vice president and chief medical officer at Caris Life Sciences. We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X, formerly known as Twitter, and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X, formerly known as Twitter: @ShikhaJainMD. Sledge can be reached via email [email protected]. Disclosures: Jain reports no relevant financial disclosures. Sledge reports that he has stock options with Syndax.